Furthermore, we also showed that alteration of SPRY4-IT1 expression can influence the expression levels of E-cadherin and vimentin proteins, indicating that SPRY4-IT1 affects NSCLC cell proliferation and metastasis partly via the epithelial–mesenchymal transition (EMT). The gene discussed is SPRY4; the disease is non-small cell lung carcinoma.